AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2015

Jun 26, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2015-06-23

Reporting Person: Cantley Lewis Clayton Jr. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-06-24	Common stock	S	2426	$104.60	Disposed	164836	Direct
2015-06-24	Common stock	S	2426	$104.59	Disposed	164836	Indirect
2015-06-25	Common stock	S	2426	$105.66	Disposed	162410	Direct
2015-06-25	Common stock	S	2426	$105.66	Disposed	162410	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-06-23	Stock option (right to buy)	$103.63	A	10625	Acquired	2025-06-22	Common stock (10625)	Direct

Footnotes

F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $103.00 to $105.97. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F3: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $103.00 to $106.47. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F4: Shares held by Vicki Lee Sato, who is the reporting person's spouse.

F5: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $104.82 to $107.30. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F6: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $104.82 to $107.28. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F7: This option was granted on June 23, 2015. The shares underlying this option vest as to 100% of the underlying shares on June 23, 2016.